WuXi PharmaTech (stock code: 603259.SH/2359.HK) provides all-round and integrated new drug research and development and production services for the global biomedical industry. Wuxi pharmatech is committed to promoting the research and development of new drugs and bringing breakthrough treatment solutions to patients by empowering global pharmaceutical, biotechnology and medical device enterprises. Based on the principle of putting research first and taking customers as the center, WuXi PharmaTech helps customers to improve their R&D efficiency. Its service scope covers the R&D and production of chemical drugs, the R&D and production of cell and gene therapy, and the testing of medical devices.
The content of this article comes from: China Law Publishing House "General Knowledge Series of Legal Life"